Search research articles

Search research articles

Related Experiment Videos

Implementing tuberculosis control programmes in Kaduna State, Nigeria

¹School of Health Services Management, Faculty of Medicine, University of New South Wales, Sydney, Australia.

The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease

|April 29, 1998

Summary

This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Influenza outbreak in a correctional facility.

Australian and New Zealand journal of public health·2001

Same author

Thabo Mbeki and the AIDS 'jury'.

Australian health review : a publication of the Australian Hospital Association·2001

Same author

Response to HBV vaccine in relation to vaccine dose and anti-HCV positivity: a New South Wales correctional facilities' study.

Vaccine·2001

Same author

Hepatitis C virus infection: a disease of poverty.

Tropical doctor·2001

Same author

Smoking prevalence in New South Wales correctional facilities, 2000.

Tobacco control·2001

Same author

Branded--tattooing in prisons.

Tropical doctor·2000

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Implementing user fees for tuberculosis treatment reduced affordability but improved compliance among paying patients. Strategies are needed to balance cost recovery with patient access to essential tuberculosis drugs.

Area of Science:

Public Health
Health Economics
Infectious Disease Management

Background:

Tuberculosis (TB) remains a significant global health challenge, necessitating effective and accessible treatment strategies.
Cost-recovery measures in healthcare, such as drug pre-payment, can impact patient access and adherence.
The Kaduna State tuberculosis pilot project explored the implications of introducing fees for TB drug therapy.

Purpose of the Study:

To evaluate the impact of pre-payment versus free drug therapy on tuberculosis case-finding and treatment outcomes.
To analyze the effects of user fees on patient affordability and treatment compliance.
To identify potential strategies for balancing cost-recovery objectives with equitable access to TB treatment.

Main Methods:

Related Experiment Videos

Comparative cohort analysis of tuberculosis patients.

Evaluation of case-finding and treatment data before and after the introduction of pre-payment.

Assessment of patient affordability and treatment compliance rates.

Main Results:

Introduction of pre-payment fees led to a reduction in the proportion of diagnosed smear-positive patients who could afford treatment.
Conversely, user fees significantly enhanced treatment compliance among patients willing and able to pay.
A trade-off was observed between cost-recovery goals and ensuring universal access to tuberculosis care.

Conclusions:

Pre-payment for tuberculosis drugs presents a complex challenge, affecting both patient affordability and treatment adherence.
Healthcare systems must consider innovative approaches to mitigate the negative impact of user fees on vulnerable populations.
Balancing financial sustainability with the imperative of widespread tuberculosis treatment access requires careful policy design and implementation.